CHRISTINE ENGLAND: Open Payments
NPI 1952581050 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 78 payments from 18 companies in 2025. Trend: 2023 $1,538 · 2024 $1,742 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $407 |
| Novo Nordisk Inc | 20 | $317 |
| Abbott Laboratories | 14 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Exact Sciences Corporation | 3 | $59 |
| Amgen Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 1 | $26 |
| Corcept Therapeutics | 1 | $23 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, BREZTRI, JARDIANCE, Kerendia, Cologuard Collection Kit, OTEZLA, Wegovy.
Industry payments across MI — which companies pay providers there.
